Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for P3 Health Partners (PIIIW) over the last 5 years, with Q3 2025 value amounting to -$865000.0.

  • P3 Health Partners' Net Cash Flow rose 9143.9% to -$865000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year decrease of 37806.34%. This contributed to the annual value of $3.2 million for FY2024, which is 8590.56% down from last year.
  • Per P3 Health Partners' latest filing, its Net Cash Flow stood at -$865000.0 for Q3 2025, which was up 9143.9% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Net Cash Flow registered a high of $57.1 million during Q2 2023, and its lowest value of -$46.8 million during Q2 2022.
  • Its 5-year average for Net Cash Flow is -$7.2 million, with a median of -$10.1 million in 2023.
  • As far as peak fluctuations go, P3 Health Partners' Net Cash Flow tumbled by 39356.89% in 2022, and later soared by 22205.63% in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Net Cash Flow stood at $672083.0 in 2021, then tumbled by 2615.17% to -$16.9 million in 2022, then grew by 2.35% to -$16.5 million in 2023, then tumbled by 45.38% to -$24.0 million in 2024, then soared by 96.4% to -$865000.0 in 2025.
  • Its last three reported values are -$865000.0 in Q3 2025, -$2.0 million for Q2 2025, and -$2.8 million during Q1 2025.